SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000891618-97-004534
Filing Date
1997-11-12
Accepted
1997-11-12 00:00:00
Documents
3
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D SC 13D 33120
2 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION EX-4.1 283329
3 FORM OF VOTING AGREEMENT EX-4.2 21112
  Complete submission text file 0000891618-97-004534.txt   339710
Mailing Address 385 OYSTER POINT BLVD SUITE 3 SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SOUTH SAN FRANCISCO CA 94080 4157378600
ARRIS PHARMACEUTICAL CORP/DE/ (Filed by) CIK: 0000913056 (see all company filings)

IRS No.: 222969941 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 11099 NORTH TORREY PINES RD SUITE 160 LA JOLLA CA 92037 6194526550
SEQUANA THERAPEUTICS INC (Subject) CIK: 0000946736 (see all company filings)

IRS No.: 330550509 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-49547 | Film No.: 97713268
SIC: 2835 In Vitro & In Vivo Diagnostic Substances